SCHEMBL30460032

SCHEMBL30460032

CC1(C)C(NC(=O)c2cccnc2)C(C)(C)C1Oc1ccc(C#N)c(Cl)c1

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 20/20 0.73
▸ CRBN Q96SW2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22565159 1.00 AR (0.73) ARCRBN
SCHEMBL22565144 0.89 AR (0.77) ARCRBN
SCHEMBL27363060 0.89 AR (0.77) ARCRBN
SCHEMBL22565160 0.89 AR (0.59) AR
SCHEMBL24266797 0.88 AR (0.74) ARCRBN
SCHEMBL17536562 0.88 AR (0.74) ARCRBN
SCHEMBL17536563 0.88 AR (0.74) ARCRBN
SCHEMBL19599918 0.86 AR (0.73) ARCRBN
SCHEMBL20045998 0.86 AR (0.73) ARCRBN
SCHEMBL22565142 0.86 AR (0.68) AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 — — WO claimed
Send feedback